HCM IV Acquisition Corp. (NASDAQ:HACQ – Get Free Report) was the recipient of a large decrease in short interest in October. As of October 15th, there was short interest totaling 44 shares, a decrease of 45.0% from the September 30th total of 80 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 74,474 shares, the days-to-cover ratio is presently 0.0 days.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings raised shares of HCM IV Acquisition from a “sell (e)” rating to a “sell (e+)” rating in a report on Friday, October 9th. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.
Check Out Our Latest Analysis on HACQ
HCM IV Acquisition Stock Performance
Shares of NASDAQ HACQ remained flat at $10.03 during trading hours on Monday. The stock had a trading volume of 7,897 shares, compared to its average volume of 67,136. The business’s 50 day moving average is $10.05. HCM IV Acquisition has a 52-week low of $9.86 and a 52-week high of $10.09.
About HCM IV Acquisition
HCM IV Acquisition Corp. is a special purpose acquisition company (SPAC) organized to identify and complete a business combination with one or more operating companies. Its potential transactions may include a merger, acquisition, share exchange, asset acquisition, reorganization or similar corporate transaction.
As a SPAC, HCM IV Acquisition Corp. does not have an operating business, products or services of its own. Before completing a business combination, its activities are generally limited to evaluating potential targets, conducting due diligence and managing funds raised through its public offering.
Publicly available information about the company’s specific target focus, geographic operations and leadership is limited.
See Also
- Five stocks we like better than HCM IV Acquisition
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for HCM IV Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCM IV Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
